Navigation Links
Michael J. Fox Foundation Awards $2 Million for Clinical Research on Postural Instability and Gait Disturbances in Parkinson's Disease
Date:12/28/2009

NEW YORK, Dec. 28 /PRNewswire-USNewswire/ -- The Michael J. Fox Foundation for Parkinson's Research has awarded a total of $2 million to five research teams carrying out clinical studies to refine understanding of postural instability and gait disturbances (PIGD) in Parkinson's disease, and help speed the development of urgently needed treatments. The funding was made possible by a generous lead gift from The Edmond J. Safra Foundation, a steadfast supporter of The Michael J. Fox Foundation's mission to speed transformative treatments and a cure for Parkinson's disease.

PIGD encompasses a constellation of Parkinson's symptoms including freezing of gait, difficulty initiating movement, shuffling, falling and other specific problems with balance. No currently available PD treatments alleviate these symptoms. Their biological causes are not well understood and may originate outside the dopamine system, as these symptoms respond inconsistently or not at all to dopamine replacement therapy.

PIGD affects only a subset of Parkinson's patients, but is associated with highly troubling clinical features: a malignant and faster-progressing disease course; increased risk of cognitive deficits and dementia; a greater likelihood of needing to enter a care facility; and risk of falling 10 times higher than that of normal-aging elderly.

  • A team at Northwestern University will build on the finding that many people with REM sleep behavior disorder (RBD) eventually develop Parkinson's disease. The researchers will investigate the possibility that RBD and freezing of gait share common abnormalities in the brain and that RBD could serve as an early warning sign for risk of Parkinson's disease dominated by PIGD and freezing of gait.
  • Researchers at the Belgian National Fund for Scientific Research will use magnetic resonance imaging (MRI) to investigate how two specific regions may interact with other areas of the brain to control gait. They will also investigate whether freezing can be alleviated through repetitive transcranial magnetic stimulation (rTMS) of one of these regions, the posterior parietal cortex (PPC). rTMS is a non-invasive method for stimulating specific areas of the brain surface through the skull.
  • A team based in Sydney, Australia, will use functional magnetic resonance imaging (fMRI) in a virtual environment to safely trigger freezing episodes while visualizing patients' brains. The researchers aim to more fully establish which regions of the brain are activated during freezing in order to open new doors to the development of treatments.

As with all MJFF awards, continued funding is dependent on researchers' achieving predetermined milestones. A full list of awardees is below. Grant abstracts and researchers' biosketches are available at www.michaeljfox.org.

Role of the Posterior Parietal Cortex and Pedunculopontine Nucleus in the Pathopysiology of Freezing of Gait: An MRI and TMS study

Julien Cremers, MD, University Hospital of Liege and Belgian National Fund for Scientific Research

The Role of White Matter Pathology in the Development of the Postural Instability and Gait Disturbance (PIGD) Type of Parkinson's disease

Jeffrey Hausdorff, Tel-Aviv Sourasky Medical Center, Israel

Determining the Neural Correlates of Freezing of Gait in Parkinson's Disease Using Functional Magnetic Resonance Imaging (fMRI)

Simon Lewis, MD, Parkinson's Disease Research Clinic, Brain & Mind Research Institute, University of Sydney, Australia

Relationship between REM Behavior Disorder and Freezing of Gait in Parkinson's Disease

Colum MacKinnon, Ph.D., Northwestern University, Chicago, Illinois

Neuroanatomical Correlates of Dopamine Responsive and Non-responsive Gait and Balance Impairment in Parkinson's Disease

Wayne Martin, MD, University of Alberta, Canada

The Michael J. Fox Foundation is dedicated to ensuring the development of better treatments, and ultimately a cure, for Parkinson's disease through an aggressively funded research agenda. MJFF has funded over $165 million in research to date.

SOURCE Michael J. Fox Foundation


'/>"/>
SOURCE Michael J. Fox Foundation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Michael J. Fox Foundation Awards $1 Million for Critical Step Toward Development of Dyskinesia Treatments
2. Rush Limbaugh & Michael Steele Join Tea Party Support & Social Security Institute-Demand GOP Senate Stop ObamaCare by Any Means Possible
3. Dr. Michael Aziz Releases a New Nutrition Book That Debunks Most Popular Diets and Diet Books
4. BIDMC scientists awarded grants from Michael J. Fox Foundation for Parkinsons research
5. Michael S. Burg Appointed as Co-Lead Counsel in the Yasmin/Yaz Multidistrict Litigation
6. Syracuse Attorney Michael P. Kenny Prepares Suit Against Sony Due to Client's Seizure Caused By Video Game
7. Majesco Entertainment and Interactive Game Group Release Jillian Michaels Fitness Ultimatum 2010 For Nintendo DS(TM)
8. Michael J. Fox Foundation Commits Up to $5 Million to Help Advance Neurotrophic Factors From Promise to Reality As Parkinsons Treatment
9. Dr. Michael Guthrie Named to PerfectServe Advisory Board
10. The Celebrate Wellness Expo Presents Motivational Speaker & Author Dr. Robin L. Smith and Spiritual Teacher & Author Rev. Michael Bernard Beckwith
11. Nurses, AFL-CIO Unions to Host Michael Moore and Special Screening of New Film at AFL-CIO Convention
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... Richmond, BC (PRWEB) , ... April 25, 2017 , ... ... patients from Richmond, BC, who live with dental fear and require sedation to receive ... anxiety at ease during various procedures, from hygienic cleanings to oral surgery, at ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... they rely on contracted partners to help with process innovation in drug formulation ... drug formulation experience along with state-of-the-art analytical equipment in support of their development ...
(Date:4/25/2017)... MN (PRWEB) , ... April 25, 2017 , ... Buyers ... and recreational users to dispensaries and head shops –can’t help but be heartened by ... for the tell-tale cannabis odor aptly described as “skunk smell.” At last they ...
(Date:4/25/2017)... ... 25, 2017 , ... Emergency Physician and Distinguished Professor of Emergency Medicine Bentley ... in Writing, set to publish in summer 2017. , Dr. Bobrow, MD, FACEP, ... Arizona College of Medicine. He also serves as Medical Director for the Bureau of ...
(Date:4/25/2017)... ... April 25, 2017 , ... Amendia, Inc., designer, developer, and ... partnership with and platinum sponsorship of Global Spine Outreach (“GSO”), a charitable organization ... of complex spine deformity cases, particularly in children. , GSO’s focus is to ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 2017 Eyevensys, a private biotechnology ... gene expression technology that enables the safe, local, sustained ... a wide range of ophthalmic diseases, announces it has ... Regulatory Agency (MHRA) to advance its technology into clinical ... The ...
(Date:4/19/2017)... , April 19, 2017 Cardiology devices segment ... projected period The Cardiology Devices segment is likely ... US$ 15 Mn in 2018 over 2017. By the end ... market valuation close to US$ 700 Mn, expanding at a ... segment dominated the Asia Pacific reprocessed ...
(Date:4/19/2017)... NEW YORK , April 19, 2017 /PRNewswire/ ... This report on the prostate cancer ... of the global market. Increasing prevalence of prostate ... as innovation in the development of new drugs ... hormone-refractory prostate cancer drug due to lesser side ...
Breaking Medicine Technology: